BioCryst Pharmaceuticals, Inc.

590 articles about BioCryst Pharmaceuticals, Inc.

• Biocryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008

  5/2/2008

• Biocryst Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update

  3/4/2008

• Biocryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008

  2/29/2008

• Biocryst Pharmaceuticals Updates Peramivir Clinical Development Plan; Company Will Not Continue Phase III

  1/24/2008

• Biocryst Pharmaceuticals Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer

  1/11/2008

• Biocryst Pharmaceuticals Data Presented at 2007 American Society of Hematology Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma

  12/14/2007

• Biocryst Pharmaceuticals Announces Presentation of Data Detailing Synergistic Activity of Forodesine HCl With Bendamustine in Chronic Lymphocytic Leukemia

  12/10/2007

• Biocryst Pharmaceuticals to Halt IV Drug Study

  12/7/2007

• Biocryst Pharmaceuticals Reports Third Quarter 2007 Financial Results and Corporate Update Lead Programs Continue Late-Stage Clinical Progress

  11/8/2007

• Biocryst Pharmaceuticals to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007

  11/6/2007

• Biocryst Pharmaceuticals Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)

  10/12/2007

• Biocryst Pharmaceuticals to Present at UBS Warburg 2007 Global Life Sciences Conference

  9/24/2007

• Biocryst Pharmaceuticals Flu Drug Misses Goal in Mid-Stage Study

  9/20/2007

• Biocryst Pharmaceuticals to Present at the BioCentury NewsMakers in the Biotech Industry Conference

  8/31/2007

• Biocryst Pharmaceuticals Reports Second Quarter 2007 Financial Results

  8/9/2007

• Biocryst Pharmaceuticals Appoints Elliott T. Berger, Ph.D., Senior Vice President of Regulatory Affairs

  8/8/2007

• Biocryst Pharmaceuticals Announces $65.3 Million Private Placement Financing

  8/6/2007

• Biocryst Pharmaceuticals to Release Second Quarter 2007 Financial Results on Thursday, August 9, 2007

  8/3/2007

• Biocryst Pharmaceuticals to Release Second Quarter 2007 Financial Results on Thursday, August 9, 2007

  8/2/2007

• Biocryst Pharmaceuticals Announces Realignment; New CFO

  7/26/2007